FlexMetric bone marrow aspirator yields laboratory and clinically improved results from mesenchymal stem and progenitor cells without centrifugation
- PMID: 36112534
- DOI: 10.1002/term.3348
FlexMetric bone marrow aspirator yields laboratory and clinically improved results from mesenchymal stem and progenitor cells without centrifugation
Abstract
Several devices used to harvest stem/progenitor cells from bone marrow are available to clinicians. This study compared three devices measuring stem cell yields and correlating those yields to bone regeneration. A flexible forward aspirating system Marrow Marxman (MM), a straight needle aspirating on withdrawal system Marrow Cellutions (MC), and a straight needle aspirating on withdrawal and centrifuging the aspirate (BMAC) were compared in a side-to-side patient comparison, as well as tissue engineered bone grafts. The FlexMetric system (MM) produced greater CFU-f values compared to the straight needle (MC) Δ = 1083/ml, p < 0.001 and 1225/ml, p < 0.001 than the BMAC system. This increased stem/progenitor cell yield also translated into a greater radiographic bone density at 6 months Δ = 88.3 Hu, p ≤ 0.001 versus MC and Δ = 116.7, p < 0.001 versus BMAC at 6 months and Δ = 72.2, p < 0.001 and Δ = 93.3, p < 0.001 at 9 months respectively. The increased stem/progenitor cell yield of the MM system clinically translated into greater bone regeneration as measured by bone volume p < 0.014 and p < 0.001 respectively, trabecular thickness p < 0.007 and p < 0.002 respectively, and trabecular separation p = 0.011 and p < 0.001. A flexible bone marrow aspirator produces higher yields of stem/progenitor cells. Higher yields of stem/progenitor cells translate into greater bone regeneration in tissue engineering. Flexmetric technology produces better bone regeneration due to a forward aspiration concept reducing dilution from peripheral blood and its ability to target lining cells along the inner cortex. Centrifugation systems are not required in tissue engineering procedures involving stem/progenitor cells due to nonviability or functional loss from g-forces.
Keywords: FlexMetric® Technology; bone regeneration; lining cells; mesenchymal stem cells; osteoprogenitor cells; tissue engineering.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation.J Transl Med. 2019 Jan 5;17(1):10. doi: 10.1186/s12967-018-1750-x. J Transl Med. 2019. PMID: 30611285 Free PMC article.
-
Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration.J Transl Med. 2019 Apr 8;17(1):115. doi: 10.1186/s12967-019-1866-7. J Transl Med. 2019. PMID: 30961655 Free PMC article.
-
A prospective comparison of 3 approved systems for autologous bone marrow concentration demonstrated nonequivalency in progenitor cell number and concentration.J Orthop Trauma. 2014 Oct;28(10):591-8. doi: 10.1097/BOT.0000000000000113. J Orthop Trauma. 2014. PMID: 24694554
-
A Review of Commercially Available Point-of-Care Devices to Concentrate Bone Marrow for the Treatment of Osteoarthritis and Focal Cartilage Lesions.Cartilage. 2019 Oct;10(4):387-394. doi: 10.1177/1947603518768080. Epub 2018 Apr 13. Cartilage. 2019. PMID: 29652173 Free PMC article. Review.
-
Troubleshooting: Quantification of mobilization of progenitor cell subsets from bone marrow in vivo.J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):113-21. doi: 10.1016/j.vascn.2010.01.013. Epub 2010 Feb 6. J Pharmacol Toxicol Methods. 2010. PMID: 20139021 Review.
References
REFERENCES
-
- Alvarez, J. G., Lasso, J. L., Blasco, L., Nuñez, R. C., Heyner, S., Caballero, P. P., & Storey, B. T. (1993, July). Centrifugation of human spermatozoa induces sublethal damage; separation of human spermatozoa from seminal plasma by a dextran swim-up procedure without centrifugation extends their motile lifetime. Human Reproduction, 8(7), 1087-1092.
-
- Barakat, A. H., Elwell, V. A., & Lam, K. S. (2019, December). Stem cell therapy in discogenic back pain. The Journal of Spine Surgery (JSS), 5(4), 561-583. https://doi.org/10.21037/jss.2019.09.22
-
- Caplan, AI. (1991, September). Mesenchymal stem cells. Journal of Orthopaedic Research, 9(5), 641-650. https://doi.org/10.1002/jor.1100090504
-
- Caplan, AI. (2017, June). Mesenchymal stem cells: Time to change the name! Stem Cells Translational Medicine, 6(6), 1445-1451. https://doi.org/10.1002/sctm.17-0051
-
- Colnot, C. (2009, February). Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. The Journal of Bone and Mineral Research (JBMR), 24(2), 274-282. https://doi.org/10.1359/jbmr.081003
MeSH terms
LinkOut - more resources
Full Text Sources